David A. Siegel Neuronetics, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Neuronetics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 50,600 shares of STIM stock, worth $93,104. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,600
Previous 51,000
0.78%
Holding current value
$93,104
Previous $147,000
63.27%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding STIM
# of Institutions
68Shares Held
18.4MCall Options Held
200Put Options Held
3.6K-
Archon Capital Management LLC Seattle, WA2.54MShares$4.67 Million4.16% of portfolio
-
Cannell Capital LLC Alta, WY2.46MShares$4.53 Million2.78% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL1.54MShares$2.83 Million1.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$2.39 Million0.0% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY1.18MShares$2.17 Million0.04% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $49.7M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...